Intellectual Property India Publishes Patent Application for 'Multispecific Antibodies And Uses Thereof' Filed by Genentech, Inc.

MUMBAI, India, Aug. 29 -- Intellectual Property India has published a patent application (202517075403 A) filed by Genentech, Inc., San Francisco, on Aug. 7, for 'multispecific antibodies and uses thereof.'

Inventor(s) include Spiess, Christoph; Wang, Baomei; Williams, Ambrose, Jon; Chiu, Cecilia, Pui Chi; Dillon, Michael, Andrew; Esen Sergin, Emel; Junttila, Teemu, Tapani; and Koerber, James, Thomas.

The application for the patent was published on Aug. 29, under issue no. 35/2025.

According to the abstract released by the Intellectual Property India: "The present invention provides anti-C-C motif chemokine receptor 8 (CCR8) antigen-binding molecules (e.g., bispecific antigen-binding molecules) and compositions thereof. The invention also features polynucleotides, vectors, host cells, methods of production, pharmaceutical compositions, methods of treating a disease or disorder, such as cancer, methods of depleting regulatory T cells, related uses and compositions for use, and kits for use with the one or more methods."

The patent application was internationally filed on Jan. 18, 2024, under International application No.PCT/US2024/012008.

Disclaimer: Curated by HT Syndication.